We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+5.89%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$35.5B
AUM Growth
+$586M
(+1.7%)
Cap. Flow
-$946M
Cap. Flow
% of AUM
-2.67%
Top 10 Holdings %
Top 10 Hldgs %
25.54%
Holding
2,317
New
189
Increased
687
Reduced
1,108
Closed
152
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
British American Tobacco
BTI
|
+$104M |
| 2 |
Occidental Petroleum
OXY
|
+$86.7M |
| 3 |
Canadian Imperial Bank of Commerce
CM
|
+$82.9M |
| 4 |
Public Storage
PSA
|
+$71.4M |
| 5 |
Alnylam Pharmaceuticals
ALNY
|
+$57.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$418M |
| 2 |
Consolidated Edison
ED
|
+$212M |
| 3 |
Crown Castle
CCI
|
+$103M |
| 4 |
Target
TGT
|
+$93.8M |
| 5 |
SAGE
Sage Therapeutics
SAGE
|
+$72M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 14.38% |
| 2 | Healthcare | 14.1% |
| 3 | Communication Services | 10.76% |
| 4 | Technology | 10.06% |
| 5 | Utilities | 9.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1101
Cohu
COHU
$2.42B
| $1.37M | ﹤0.01% |
62,463
+272
| +0.4% | +$6.49K |
|
|
RVNC
1102
DELISTED
Revance Therapeutics, Inc.
RVNC
| $1.37M | ﹤0.01% |
38,285
-12,000
| -24% | -$345K |
|
|
TTSH
1103
DELISTED
Tile Shop Holdings
TTSH
| $1.36M | ﹤0.01% |
142,030
+140,377
| +8,492% | +$1.24M |
|
1104
First Guaranty Bancshares
FGBI
$140M
| $1.36M | ﹤0.01% |
65,910
+369
| +0.6% | +$7.59K |
|
1105
First Busey Corp
BUSE
$2.5B
| $1.34M | ﹤0.01% |
+44,744
| New | +$1.39M |
|
|
PX
1106
DELISTED
Praxair Inc
PX
| $1.34M | ﹤0.01% |
8,658
-1,170
| -12% | -$174K |
|
1107
Capri Holdings
CPRI
$1.67B
| $1.33M | ﹤0.01% |
21,155
-9,294
| -31% | -$509K |
|
1108
Nice
NICE
$6.18B
| $1.33M | ﹤0.01% |
14,454
| – | – |
|
1109
First Business Financial Services
FBIZ
$600M
| $1.33M | ﹤0.01% |
59,933
-8,075
| -12% | -$183K |
|
1110
Columbia Banking Systems
COLB
$8.41B
| $1.32M | ﹤0.01% |
30,473
-13,561
| -31% | -$592K |
|
|
AIMT
1111
DELISTED
Aimmune Therapeutics
AIMT
| $1.32M | ﹤0.01% |
35,000
+15,000
| +75% | +$484K |
|
1112
Jack in the Box
JACK
$253M
| $1.32M | ﹤0.01% |
13,486
+2,855
| +27% | +$290K |
|
1113
Western New England Bancorp
WNEB
$276M
| $1.32M | ﹤0.01% |
121,276
-1,360
| -1% | -$14.5K |
|
|
MDRX
1114
DELISTED
Veradigm Inc. Common Stock
MDRX
| $1.32M | ﹤0.01% |
90,708
+3,301
| +4% | +$45.9K |
|
|
FIT
1115
DELISTED
Fitbit, Inc. Class A common stock
FIT
| $1.32M | ﹤0.01% |
230,904
-15,676
| -6% | -$99.8K |
|
|
EXPR
1116
DELISTED
Express, Inc.
EXPR
| $1.32M | ﹤0.01% |
6,481
-3,223
| -33% | -$529K |
|
1117
Fossil Group
FOSL
$315M
| $1.31M | ﹤0.01% |
168,771
-1,024
| -0.6% | -$7.93K |
|
|
P
1118
Everpure Inc
P
$32.5B
| $1.31M | ﹤0.01% |
+82,455
| New | +$1.37M |
|
1119
World Kinect Corp
WKC
$1.81B
| $1.31M | ﹤0.01% |
46,495
-3,635
| -7% | -$110K |
|
1120
Host Hotels & Resorts
HST
$14.9B
| $1.3M | ﹤0.01% |
65,431
-12,201
| -16% | -$239K |
|
1121
Heron Therapeutics
HRTX
$60.3M
| $1.3M | ﹤0.01% |
+71,597
| New | +$1.17M |
|
1122
Cable One
CABO
$107M
| $1.29M | ﹤0.01% |
1,836
-301
| -14% | -$212K |
|
|
ENZ
1123
DELISTED
Enzo Biochem, Inc.
ENZ
| $1.29M | ﹤0.01% |
158,080
+426
| +0.3% | +$4.07K |
|
1124
Movado Group
MOV
$735M
| $1.28M | ﹤0.01% |
39,823
+7,343
| +23% | +$213K |
|
|
UNT
1125
DELISTED
UNIT Corporation
UNT
| $1.28M | ﹤0.01% |
58,002
+17,682
| +44% | +$357K |
|
Similar funds
Federated Hermes's Q4 2017 Portfolio in Review
As of Q4 2017, Federated Hermes held 2,317 positions worth $35.5B, up 1.7% from $34.9B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Federated Hermes's Q4 2017 filing shows 189 new, 687 increased, 1,108 reduced and 152 closed positions. Its largest new stake was Azul: 1,190,200 shares worth $28.4M. The largest sale was AbbVie, an estimated $418M.
By sector, the portfolio is most concentrated in Consumer Staples at 14% of assets, up from 14% a quarter earlier, followed by Healthcare and Communication Services.
- Federated Hermes's largest Q4 2017 buy was Azul: 1,190,200 shares worth $28.4M.
- Federated Hermes added most to British American Tobacco in Q4 2017, an estimated $104M increase.
- Federated Hermes's biggest Q4 2017 reduction was AbbVie, cutting an estimated $418M.
- Federated Hermes fully exited iShares Biotechnology ETF in Q4 2017, selling an estimated $36.1M.
- Federated Hermes's ten largest holdings make up 26% of its $35.5B portfolio in Q4 2017.
- Federated Hermes opened 189 new positions and closed 152 in Q4 2017.
- Federated Hermes's portfolio value rose 1.7% quarter-over-quarter to $35.5B.
Based on Federated Hermes's 13F filing for Q4 2017, filed 14 Feb 2018.